Summary: GLP-1 receptor agonists produce modest reductions in total cholesterol, LDL cholesterol, and triglycerides, but are not licensed or recommended as primary treatments for dyslipidaemia
That percentage is even higher among women ages 50 to 64, where 20% of that population has taken a GLP-1 agonist drug
Latvala, S., Jacobsen, B., Otteneder, M
They work by mimicking a naturally occurring hormone in the body called GLP-1 (glucagon-like peptide-1), a hormone that is released in the gut and brain when you eat 1-4 and has many complex metabolic roles including
At Join Josie, we only serve women over 35 that have started perimenopause or in menopause
The clinical evidence is robust